Literature DB >> 20027103

Psoriasis induced by losartan therapy: a case report and review of the literature.

Gurpreet Lamba1, Chandrasekar Palaniswamy, Tarunjit Singh, Dhaval Shah, Sonia Lal, Ravi Vinnakota, Elliott J Charrow, Leanne Forman.   

Abstract

Psoriasis is a papulosquamous disease of multifactorial etiology. A combination of genetic and environmental agents is implicated in its pathogenesis. A variety of triggers, including infection, stress, and medications, have been recognized as precipitants of this disease. Nonsteroidal anti-inflammatory drugs, beta-blockers, lithium, synthetic antimalarials, and gold are the most common drugs implicated in precipitating psoriasis. We report a patient with psoriasis induced by initiation of losartan therapy, which resolved with discontinuation of the drug. The Naranjo adverse drug reaction probability scale score indicated that the association between losartan use and psoriasis was probable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20027103     DOI: 10.1097/MJT.0b013e3181c6c0c2

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  6 in total

1.  Identification of a missense variant in LNPEP that confers psoriasis risk.

Authors:  Hui Cheng; Yang Li; Xian-Bo Zuo; Hua-Yang Tang; Xian-Fa Tang; Jin-Ping Gao; Yu-Jun Sheng; Xian-Yong Yin; Fu-Sheng Zhou; Chi Zhang; Gang Chen; Jun Zhu; Qian Pan; Bo Liang; Xiao-Dong Zheng; Pan Li; Yan-Tao Ding; Fang Cheng; Jing Luo; Rui-Xue Chang; Gong-Bu Pan; Xing Fan; Zai-Xing Wang; An-Ping Zhang; Jian-Jun Liu; Sen Yang; Liang-Dan Sun; Xue-Jun Zhang
Journal:  J Invest Dermatol       Date:  2013-07-29       Impact factor: 8.551

2.  Telmisartan aggravates pustular psoriasis.

Authors:  Subramaniam Keerthi; Murugaiyan Rangaraj; Kaliaperumal Karthikeyan
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun

3.  Triggering drug use in patients with psoriasis: an investigative report from Turkey.

Authors:  Zerrin Ogretmen; Ulku Askin; Meliha Merve Hiz; Sibel Cevizci
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

Review 4.  Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions.

Authors:  Liv Eidsmo; Elisa Martini
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

Review 5.  Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.

Authors:  Stefano Piaserico; Gloria Orlando; Francesco Messina
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

6.  Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.